Use Of Empiric Broad-Spectrum Antibiotics Has Increased Among Patients With Suspected Community-Onset Sepsis, Including Those Without Evidence Of Antimicrobial-Resistant Pathogens, Study Finds

Infectious Disease Advisor (7/31, Chan) reports, “The use of empiric broad-spectrum antibiotics has increased among patients with suspected community-onset sepsis, including in those with no evidence of antimicrobial-resistant pathogens,” according to a study. Investigators found that “among patients with suspected sepsis, 30,617 (3.4%) had resistant gram-positive pathogens, 38,844 (4.3%) had resistant gram-negative pathogens, and 65,434 (7.3%) had either resistant gram-positive or gram-negative pathogens.” The findings were published in JAMA Network Open.